The Public Authority for Special Economic Zones and Free Zones (OPAZ) is participating in the Milan Pharmaceutical Industries Exhibition 2026, which will take place in Milan, Italy, from October 4 to 6.

This forms part of the Government’s drive to establish specialised industrial clusters for pharmaceuticals and medical devices in economic, free and industrial zones. The aim is to strengthen pharmaceutical security, support the localisation of pharmaceutical and medical industries, and attract high-quality investments.

The OPAZ delegation at the exhibition is headed by Ahmed bin Hassan Al Dheeb, Vice Chairman of the authority, and includes representatives from government and private-sector entities.

The event will showcase the investment opportunities offered by the zones to international companies. Meetings will also be held with manufacturers and investors to explore opportunities for new projects and partnerships and to capitalise on Oman’s strategic location, advanced infrastructure and logistics networks to access regional and international markets.

OPAZ is participating with Oman Exports in the Milan Pharmaceutical Industries Exhibition amid the rapid growth of Oman’s pharmaceutical and medical industries sector. This growth reflects the development of Omani companies’ capabilities and competitiveness, alongside rising sector exports and the expansion of Omani products into more international markets.

Through this event Oman aims to promote its pharmaceutical and medical products, strengthen the presence of Omani companies in international markets, explore new export opportunities and build commercial partnerships with international buyers and importers. It also plans to showcase the industrial and investment capabilities of Oman’s pharmaceutical and medical sector.

OPAZ is working with relevant entities, developers and operators to prepare these industrial clusters to attract specialised local and international companies. The aim is to develop an integrated investment ecosystem that supports manufacturing, storage, distribution and export operations, while providing an appropriate environment for the growth of pharmaceutical and medical industries and related activities.